The move is part of the company’s plan to strengthen its delivery capability in technically complex fit-out projects within the healthcare and research & development sectors.
ISG has recently worked on specialist fit-out projects at Guy's Hospital in London for Cell Therapy Catapult and also a new research facility at the Natural History Museum. Paul Sharp is currently working on a new stem cell laboratory for King’s College London.
In his new role, Mr Sharp will lead ISG’s bid for opportunities in the forthcoming Medcity in London, which will collaborate with the universities of Oxford and Cambridge to form a world-leading bioscience cluster, where there is significant planned investment in R&D facilities and laboratories. He will also drive the roll out of ISG’s specialist fit-out business nationwide.
Mr Sharp said: “My new role represents a strategic decision by the company to capitalise on many of the world-class technical fit-out projects that ISG has delivered, creating a formal structure to take that expertise to the marketplace as a defined service offer. The success of the bioscience cluster in attracting ground breaking academic research and commercial scientific companies from across the world provides considerable opportunity for the business, with its strong credentials delivering highly complex and mission critical projects.”